← Eichor
Study identifier: NCT07460076 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone

Condition: Alveolar Bone Loss · Esthetic Zone Implant Rehabilitation  ·  Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City

PhaseNA
Planned participants15
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Immediate implant placement in the esthetic zone is often associated with buccal bone deficiency, which may compromise esthetic outcomes and long-term implant stability. Autogenous bone graft harvested from the maxillary tuberosity provides corticocancellous bone with favorable biological properties and may help reconstruct the buccal bone plate during immediate implant placement. This prospective case series aims to evaluate the clinical and esthetic outcomes of immediate implant placement combined with autogenous maxillary tuberosity graft in the esthetic zone. The primary outcomes include buccal bone thickness measured on cone-beam computed tomography (CBCT), facial soft tissue thickness measured clinically, and the pink esthetic score (PES) after implant restoration.

This description comes directly from the study's public registry record.

Talk to the study team

Duy Anh Tran, DDS  ·  +84 868324216  ·  tranduyanhump17@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

University of Medicine and Pharmacy at Ho Chi Minh CityHo Chi Minh City, Ho Chi Minh, VietnamRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07460076